摘要
目的分析讨论派罗欣联合利巴韦林治疗慢性丙肝的临床效果。方法选取2013年3月~2015年1月我院收治的慢性丙肝患者80例作为研究对象,将其随机分为两组,普通组用药方案为普通干扰素、利巴韦林联合,长效组患者用药方案为长效干扰素派罗欣、利巴韦林联合,分别比较两组患者治疗效果、复发率和副作用。结果治疗后,长效组患者早期应答率高于普通组,无效率、复发率和副作用低于普通组,P〈0.05。结论采用派罗欣联合利巴韦林治疗慢性丙肝的临床效果确切,可提高治疗效果,降低复发率,药物毒副作用少,安全性高。
Objective Analysis pegasys plus ribavirin treatment the clinical effect of chronic hepatitis c. Methods Select from March 2013 to January 2015 of our hospital, 80 cases of patients with chronic hepatitis c as the research object, it is divided into two groups at random, for ordinary ordinary group regimen interferon and ribavirin combination, long- term patients regimen for pegasys long-acting interferon and ribavirin combination, respectively to compare the effect, the recurrence rate and side effects of two groups of patients. Results Long-term results after treatment, the group of patients with early response rate is significantly higher than normal group, no efficiency, the recurrence rate and side effects was significantly lower than normal group. P〈0.05. Conclusion Use pegasys plus ribavirin in the treatment of chronic hepatitis c effect is exact, can improve the treatment effect, reduce recurrence rate, less drug side effects, high security.
出处
《继续医学教育》
2016年第1期147-148,共2页
Continuing Medical Education
关键词
派罗欣
利巴韦林
慢性丙肝
临床效果
Pegasys, Ribavirin, Chronic hepatitis C, Clinical effect
